India to extend grants for pharma research for clinical trials for neglected tropical research
The Cabinet Committee on Economic Affairs today gave its approval for extending grants-in-aid to Indian Pharmaceutical Industry for R&D projects involving Clinical Trials (Phase-I, II and III) to develop new drugs for neglected diseases of tropical region under Drugs & Pharmaceuticals Research Programme of Department of Science & Technology.
Deptt. of S&T has been implementing the Drugs & Pharmaceuticals Research Programme (DRPR) since 1994-95 as a Plan Programme to support pharma industry – institutional collaboratrive R&D projects and infrastructure development. From 2004-05 onwards this programme has extended soft loans to pharma industries for R&D projects to the tune of 70% of total project cost at a simple annual rate of interest of 3% with 10 years of instalment repayment period beginning from the end of project duration.
An amount of Rs.45.00 crore during the 11th Five Year Plan has been earmarked to help Pharma Industry. This amount can be enlarged as the programme develops further .
It would help in developing new drugs for the neglected diseases of tropical region such as Tuberculosis, Malaria, Kala-azar, filariasis etc. which are still a big threat in the Indian sub-continent.
You must be logged in to post a comment.